61 related articles for article (PubMed ID: 12944990)
1. E6AP gene suppression and characterization with in vitro selected hammerhead ribozymes.
Kim Y; Cairns MJ; Marouga R; Sun LQ
Cancer Gene Ther; 2003 Sep; 10(9):707-16. PubMed ID: 12944990
[TBL] [Abstract][Full Text] [Related]
2. Involvement of a cellular ubiquitin-protein ligase E6AP in the ubiquitin-mediated degradation of extensive substrates of high-risk human papillomavirus E6.
Matsumoto Y; Nakagawa S; Yano T; Takizawa S; Nagasaka K; Nakagawa K; Minaguchi T; Wada O; Ooishi H; Matsumoto K; Yasugi T; Kanda T; Huibregtse JM; Taketani Y
J Med Virol; 2006 Apr; 78(4):501-7. PubMed ID: 16482544
[TBL] [Abstract][Full Text] [Related]
3. Stepwise multipolyubiquitination of p53 by the E6AP-E6 ubiquitin ligase complex.
Masuda Y; Saeki Y; Arai N; Kawai H; Kukimoto I; Tanaka K; Masutani C
J Biol Chem; 2019 Oct; 294(41):14860-14875. PubMed ID: 31492752
[TBL] [Abstract][Full Text] [Related]
4. A ubiquitin variant-based affinity approach selectively identifies substrates of the ubiquitin ligase E6AP in complex with HPV-11 E6 or HPV-16 E6.
Ebner FA; Sailer C; Eichbichler D; Jansen J; Sladewska-Marquardt A; Stengel F; Scheffner M
J Biol Chem; 2020 Oct; 295(44):15070-15082. PubMed ID: 32855237
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Bak-induced apoptosis by HPV-18 E6.
Thomas M; Banks L
Oncogene; 1998 Dec; 17(23):2943-54. PubMed ID: 9881696
[TBL] [Abstract][Full Text] [Related]
6. c-Abl phosphorylates E6AP and regulates its E3 ubiquitin ligase activity.
Chan AL; Grossman T; Zuckerman V; Campigli Di Giammartino D; Moshel O; Scheffner M; Monahan B; Pilling P; Jiang YH; Haupt S; Schueler-Furman O; Haupt Y
Biochemistry; 2013 May; 52(18):3119-29. PubMed ID: 23581475
[TBL] [Abstract][Full Text] [Related]
7. HPV E6 degradation of p53 and PDZ containing substrates in an E6AP null background.
Massimi P; Shai A; Lambert P; Banks L
Oncogene; 2008 Mar; 27(12):1800-4. PubMed ID: 17934525
[TBL] [Abstract][Full Text] [Related]
8. E3 ubiquitin ligase E6AP-mediated TSC2 turnover in the presence and absence of HPV16 E6.
Zheng L; Ding H; Lu Z; Li Y; Pan Y; Ning T; Ke Y
Genes Cells; 2008 Mar; 13(3):285-94. PubMed ID: 18298802
[TBL] [Abstract][Full Text] [Related]
9. Antisense targeting of E6AP elevates p53 in HPV-infected cells but not in normal cells.
Beer-Romero P; Glass S; Rolfe M
Oncogene; 1997 Feb; 14(5):595-602. PubMed ID: 9053858
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia induces p53 accumulation through MDM2 down-regulation and inhibition of E6-mediated degradation.
Alarcón R; Koumenis C; Geyer RK; Maki CG; Giaccia AJ
Cancer Res; 1999 Dec; 59(24):6046-51. PubMed ID: 10626788
[TBL] [Abstract][Full Text] [Related]
11. Structural dynamics of the E6AP/UBE3A-E6-p53 enzyme-substrate complex.
Sailer C; Offensperger F; Julier A; Kammer KM; Walker-Gray R; Gold MG; Scheffner M; Stengel F
Nat Commun; 2018 Oct; 9(1):4441. PubMed ID: 30361475
[TBL] [Abstract][Full Text] [Related]
12. Role of ubiquitin and the HPV E6 oncoprotein in E6AP-mediated ubiquitination.
Mortensen F; Schneider D; Barbic T; Sladewska-Marquardt A; Kühnle S; Marx A; Scheffner M
Proc Natl Acad Sci U S A; 2015 Aug; 112(32):9872-7. PubMed ID: 26216987
[TBL] [Abstract][Full Text] [Related]
13. Identification of annexin A1 as a novel substrate for E6AP-mediated ubiquitylation.
Shimoji T; Murakami K; Sugiyama Y; Matsuda M; Inubushi S; Nasu J; Shirakura M; Suzuki T; Wakita T; Kishino T; Hotta H; Miyamura T; Shoji I
J Cell Biochem; 2009 Apr; 106(6):1123-35. PubMed ID: 19204938
[TBL] [Abstract][Full Text] [Related]
14. HPV16 E6 confers p53-dependent and p53-independent phenotypes in the epidermis of mice deficient for E6AP.
Shai A; Nguyen ML; Wagstaff J; Jiang YH; Lambert PF
Oncogene; 2007 May; 26(23):3321-8. PubMed ID: 17130828
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
Luzi E; Papucci L; Schiavone N; Donnini M; Lapucci A; Tempestini A; Witort E; Nicolin A; Capaccioli S
Cancer Gene Ther; 2003 Mar; 10(3):201-8. PubMed ID: 12637941
[TBL] [Abstract][Full Text] [Related]
16. Effects on tumor cells of ribozymes that cleave the RNA transcripts of human papillomavirus type 18.
Chen Z; Kamath P; Zhang S; St John L; Adler-Storthz K; Shillitoe EJ
Cancer Gene Ther; 1996; 3(1):18-23. PubMed ID: 8785706
[TBL] [Abstract][Full Text] [Related]
17. E6AP ubiquitin ligase mediates ubiquitin-dependent degradation of peroxiredoxin 1.
Nasu J; Murakami K; Miyagawa S; Yamashita R; Ichimura T; Wakita T; Hotta H; Miyamura T; Suzuki T; Satoh T; Shoji I
J Cell Biochem; 2010 Oct; 111(3):676-85. PubMed ID: 20589759
[TBL] [Abstract][Full Text] [Related]
18. Structural insights into the functional mechanism of the ubiquitin ligase E6AP.
Wang Z; Fan F; Li Z; Ye F; Wang Q; Gao R; Qiu J; Lv Y; Lin M; Xu W; Luo C; Yu X
Nat Commun; 2024 Apr; 15(1):3531. PubMed ID: 38670961
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus E6-induced degradation of E6TP1 is mediated by E6AP ubiquitin ligase.
Gao Q; Kumar A; Singh L; Huibregtse JM; Beaudenon S; Srinivasan S; Wazer DE; Band H; Band V
Cancer Res; 2002 Jun; 62(11):3315-21. PubMed ID: 12036950
[TBL] [Abstract][Full Text] [Related]
20. Hammerhead ribozymes targeted to the FBN1 mRNA can discriminate a single base mismatch between ribozyme and target.
Phylactou LA; Tsipouras P; Kilpatrick MW
Biochem Biophys Res Commun; 1998 Aug; 249(3):804-10. PubMed ID: 9731217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
